Saturday, 13 April 2019

Benign Prostatic Hyperplasia




Answer: e- Moxonidine

Doxazosin, Terazosin, Prazosin and Indoramin are all indicated in Benign Prostatic Hyperplasia. Moxonidine is new centrally acting imidazoline α2 agonist which is used to treat hypertension when all other means of treatment with thiazide diuretics, calcium channel blockers, beta blockers and ACE Inhibitors fail.

No comments:

Post a Comment